SUPN Net Income Growth
Supernus Pharmaceuticals Inc · Net Income Growth
SUPN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-270.37%period ending
SUPN TTM Net Income YoY % (250.51% → -270.37%)
Year-over-year change
High-resolution chart · PNG
SUPN net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -270.3738% | |
| -146.865% | |
| -152.1898% | |
| -132.0153% | |
| 1,131.0937% | |
| 499.2391% | |
| 5,512.8419% | |
| 133.0497% | |
| -87.9138% | |
| -129.7984% | |
| -97.8324% | |
| -31.9866% | |
| -24.5942% | |
| -29.0445% | |
| 13.6399% | |
| -53.918% | |
| -42.6212% | |
| -33.9974% | |
| -57.9173% | |
| -36.7803% | |
| -15.2225% | |
| -4.3946% | |
| 12.2895% | |
| 22.199% | |
| 12.5778% | |
| 12.8694% | |
| 1.8587% | |
| 7.1508% | |
| 21.0626% | |
| 40.4178% | |
| 93.7592% | |
| 70.434% | |
| -16.4743% | |
| -24.1527% | |
| -37.2031% | |
| -30.8309% | |
| 301.3842% | |
| 435.725% | |
| 553.352% | |
| 631.8976% | |
| -26.9159% | |
| -50.0761% | |
| -29.7403% | |
| 266.1489% | |
| 160.1397% | |
| 140.4387% | |
| 121.5361% | |
| 91.7377% | |
| 19.1328% | |
| -61.3143% | |
| -99.3626% | |
| -269.4213% | |
| -237.391% | |
| -199.6816% | |
| -185.9882% | |
| 233.9796% | |
| 250.5145% |